Peter Holt
Analyst · Lake Street Capital. Please proceed
Thank you, Kirsten. And thank you all for joining us. I'm delighted to speak with you today and pleased to report our continued forward momentum including seven quarter, consecutive quarters of positive adjusted EBITDA. We've moved beyond stabilizing the business and now are driving accelerated growth and profitability. We remain focused on delivering the key initiatives that drive the company's success, executing our franchise development and regional development strategies, accelerating expansion of our corporate clinic portfolio within clustered locations, improving corporate clinic performance, increasing new patient counts, stabilizing and improving the security of our IT platform, increasing cash and strengthening our balance sheet, achieving positive GAAP net income and increasing shareholder value. As a result, we've delivered one of the strongest quarters to date. I'll review the key metrics for Q1 2019 compared to the same period last year. We sold 30 franchise licenses compared to 16 in Q1 2018. We opened 12 new franchise clinics and two company owned managed -- company owned or managed greenfield for a total of 14 units compared to seven franchise and no corporate openings in Q1 2018. Turning to Slide 4, gross system wide sales grew 32% quarter-over-quarter. System wide comp sales or same store retail sales of clinics that have been opened for at least 13 months increased 25%. Our bottom line continues to improve reflecting sustainable profitability. Once again in this quarter, we've achieved positive GAAP net income of $1 million. And adjusted EBITDA was positive for the seventh consecutive quarter at $1.5 million. Further, our unrestricted cash and cash equivalents were what $8.1 million at March 31, 2019 compared to $8,7 million on December 31, 2018. Our strengthened balance sheet supports our expansion strategy. Before we get into the details, I'd like to welcome our newer investors and provide some background on our company. The foundation of The Joint is to revolutionize access to chiropractic care. We do this in a convenient retail setting providing concierge style membership-based services with no appointments, no insurance and convenient hours of operation including evenings and weekends. The Joint's purpose is to alleviate pain and help move our patients toward a healthier lifestyle. The sweet spot of the growing health and wellness industry. The Joint's mission is to improve the quality of life through routine and affordable chiropractic care. Our doctors focus on patient care, on the pain relief and ongoing wellness to help our patients live the best version of themselves. Patients are attracted to The Joint due to our accessibility, credibility and empathy as verified by the extensive consumer research we conducted in 2018. This architecture will guide us as we enhance our brand building efforts in 2019. Turning to Slide 5, let's review the portfolio during the first quarter. Regarding franchises, we opened 12 clinics, bought back one unit and closed one unit for a net increase of 10 bringing the total franchise count as of March 31, 2019 to 404. Regarding company owned or managed clinics, we opened our first two greenfield since 2016. The Carlsbad, California location grand opening was in February and the Azusa California opening took place in March. In addition, we've acquired franchise clinic in Los Angeles in March. In Costa Mesa, California, we consolidated two nearby corporate clinics into one. Net, the March 31 2019 we reached 50 company owned or managed clinics. Notably after the quarter closed. We opened our third greenfield clinic in -- for the year in Flagstaff. Further expanding our Arizona portfolio. We expect this to be the only additional corporate greenfield clinic in Q2. Our full year 2019 guidance is open to -- is to open eight to 12 company-owned or managed clinics. Through the end of April 2019, we grew our company portfolio by four consisting of three greenfield and one acquisition. This compares to one acquisition in the same period of 2018. At March 31, 2019, we had a total of 454 clinics, 89% were franchise clinics and 11% were company-owned and managed clinics. Turning to Slide 6, we continue to experience positive impact of our operational efforts. Traditionally, a well performing small box retail franchise achieves break even in six months to nine months. Thanks to the new operational tools and protocols that we developed. We've accomplished this goal. We've reduced the time from opening to break even from our historical average of 18 to 24 months to 9 months in 2017 and approximately six months in 2018. For our greenfield clinics, we are using the same programs to tame similar success. And our early 2019 trend is as strong or better than the 2018 class. Importantly, the impact of this success is ongoing as we have evidence that clinics that start strong, tend to stay strong. Turning to Slide 7, let's discuss one of our key growth drivers, our regional developer or RD program. Today, our RD support three quarters of our franchisees and cover almost half the metropolitan statistical areas in the United States. Their work enables us to leverage and accelerate The Joint franchise concept. RDs continue to perform to their expectation and were responsible for 100% of our 30 franchise license sales and some of these were multi-unit sales. Every April, we tend to experience a higher number of franchise sales prior to our annual update of the franchise disclosure document or the FDD. In April 2019, we sold 30 franchise licenses bringing the year to date to 60. This compares to 27 franchise license sales for the same period last year. Traditionally, we expect franchise license sales to be a little slower for the rest of the quarter as we go through each state's approval process for the new FDD. We closed the first quarter with 21 IDs identical to the number at the end of 2018. From time to time as the territory matures, we have the potential to repurchase or regenerate patriot the royalty stream. This quarter, we bought back the rights of South Carolina which had 23 operating units. We also continue to expand in newer regions. In March, we sold territory rights for Pittsburgh, Pennsylvania, West Virginia and a portion of Virginia to a longtime existing RD who originally purchased the rights in North Carolina and is seeking to expand his business. This territory carries a minimum 10-year development schedule of 40 units. In aggregate, our total 10 year minimum development schedule for the 15 new RDs comes to 421 clinics. This large foundation of unit commitment bodes well for continued clinic expansion and sales growth in 2019 and beyond. Turning to Slide 8, let's review marketing. We continue to work to enhance our marketing methodology and optimize our tactics not only in lead generation but also in awareness building and existing patient engagement. Our marketing foundation is built upon a robust SEO practice which delivered a record number of organic leads to our clinics in Q1 and which is increasingly important source for new leads for us. We've also improved our ability to convert these prospects by enhancing our lead nurturing campaigns and training our franchisees on how to leverage our tools. We're also utilizing digital marketing tactics to boost the overall awareness of the brand and the benefits of chiropractic care. For example in Q1, we aired TV spots to targeted customers in each of our clinic trade areas via the YouTube platform. We believe campaigns like these are helping to attract people who've never tried chiropractic before which now compromises 26% of our new patient. We're working to grow collaboration and investment by our local advertising co-ops. One example of this is our Raleigh Durham co-op which recently entered into an exclusive partnership with famed minor league baseball club, the Durham Bulls. This strategy is paying dividends in marketing throughout the country allowing increased marketing sophistication at the local level. In 2019 we'll add this increased effort on our patient relationship or CRM marketing through tactics like email and SMS. Additionally, we're actively developing new advertising assets for our franchisees, leveraging the insights gained from our 2018 consumer research and our new brand architecture. Turning to Slide 9, we continue to be excited about the progress in implementing our new more robust IT platform. We've completed the design and development stage and now are in the testing and training. Frankly, we've been very deliberate with our testing and training to ensure we minimize the impact to our business as we go through this transition. Ultimately, we believe that we can use this platform to better understand our patient behavior, laying the foundation for even more sophisticated consumer marketing. Overall, we continue to deliver strong quarterly performance and we believe that we're well-positioned to drive continued momentum. And with that, I'll turn the call over to Jake Singleton, our CFO to review the financial results.